Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2022-05-10 Regulatory Filings
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec and Bristol Myers Squibb extend and expand strategic partnership in protein degradation
Regulatory Filings Classification · 1% confidence The document is a press release dated May 10, 2022, announcing the extension and expansion of a strategic partnership between Evotec SE and Bristol Myers Squibb regarding protein degradation. It details financial terms ($200M upfront, $5BN potential) and mentions an upcoming conference call on May 11, 2022, to discuss the partnership. This type of announcement, which details a significant business development, partnership, or material event outside of standard periodic financial reports (like 10-K or IR), is typically disseminated via a regulatory news service (like DGAP, which is mentioned) or as a general corporate news release. Since it is not a formal financial report (10-K, IR, ER, MRQ), nor a specific filing like Director's Dealing (DIRS) or Proxy (DEF 14A), and it is not merely announcing the publication of another report (RPA), the most appropriate general category for a significant, non-standard corporate update disseminated via a news service is Regulatory Filings (RNS), which serves as a broad category for such announcements.
2022-05-10 English
Evotec and Bristol Myers Squibb extend and expand strategic partnership
M&A Activity Classification · 1% confidence The document is labeled as an 'Ad-hoc' release dated May 10, 2022, and explicitly states it is an 'Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014'. This type of mandatory disclosure regarding significant corporate events (like a major partnership extension and financial terms) that are not standard periodic reports (10-K, IR) or specific shareholder actions (DIV, DVA) typically falls under general regulatory announcements. Since it is a specific, non-periodic, material event disclosure mandated by EU regulation (MAR), and it doesn't fit the definitions for M&A (TAR), Capital Change (CAP/SHA), or Director Dealing (DIRS), the most appropriate general category for mandatory regulatory news that isn't a standard report is 'Regulatory Filings' (RNS). The document length is short (2650 chars), suggesting it is an announcement, not the full underlying agreement details.
2022-05-10 English
Evotec SE to announce results for the first quarter 2022 on 11 May 2022
Report Publication Announcement Classification · 1% confidence The document is a short corporate news release dated May 4, 2022, announcing that Evotec SE will release its financial results for the first quarter of 2022 on May 11, 2022. It provides details for an upcoming conference call and webcast. Since this document is an announcement *about* the future release of financial results (Q1 results) and not the results themselves (which would be an ER or IR), and it is a formal regulatory news dissemination (indicated by DGAP-News), it fits the definition of a Report Publication Announcement (RPA). It is not the full report (10-K or IR), nor is it a general earnings release (ER) which typically contains the actual figures.
2022-05-04 English
Annual financial report 2021 (PDF)
Audit Report / Information Classification · 1% confidence The document text provided is a table of contents or index page from a comprehensive corporate report. Key phrases include 'Supervisory Board Report', 'Combined Management Report pursuant to section 315 paragraph 5 of the German Commercial Code for the financial year 2021', 'Report on economic position of the Evotec Group', and 'Management Board's general assessment of Evotec's economic situation'. These elements strongly indicate a full annual report covering the entire fiscal year (2021) and containing management and supervisory board commentary, which aligns perfectly with the definition of a 10-K (Annual Report), even though the specific SEC form name '10-K' is not present, the content structure is that of an annual report. Given the comprehensive nature and the reference to the full financial year, the classification is Annual Report (10-K). The document length is also substantial (788,036 chars), confirming it is the report itself, not just an announcement. FY 2021
2022-04-28 English
Annual financial report 2021 (PDF)
Audit Report / Information Classification · 1% confidence The document text provided is a table of contents or index page from a comprehensive corporate report. Key phrases include 'Supervisory Board Report', 'Combined Management Report pursuant to section 315 paragraph 5 of the German Commercial Code for the financial year 2021', 'Report on economic position of the Evotec Group', and 'Management Board's general assessment of Evotec's economic situation'. These elements strongly indicate a full annual report covering the entire fiscal year (2021) and containing management and supervisory board commentary, which aligns perfectly with the definition of a 10-K (Annual Report), even though the specific SEC form name '10-K' is not present, the content structure is that of an annual report. Given the comprehensive nature and the reference to the full financial year, the classification is Annual Report (10-K). The document length is also substantial (788,036 chars), confirming it is the report itself, not just an announcement. FY 2021
2022-04-28 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' in Evotec SE by T. Rowe Price Group, Inc. It specifies the date the threshold was crossed (12 Apr 2022) and details the percentage of voting rights held (10.03%). This content directly corresponds to regulatory filings concerning changes in significant share ownership, which matches the definition for Major Shareholding Notification (MRQ). Although it is disseminated via DGAP (which might suggest RNS), the specific content is clearly about share ownership thresholds being crossed.
2022-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.